×
验证码:
换一张
Forgotten Password?
Stay signed in
Login With UMPASS
English
|
繁體
Login With UMPASS
Log In
ALL
ORCID
TI
AU
PY
SU
KW
TY
JN
DA
IN
PB
FP
ST
SM
Study Hall
Image search
Paste the image URL
Home
Faculties & Institutes
Scholars
Publications
Subjects
Statistics
News
Search in the results
Faculties & Institutes
Faculty of Healt... [2]
Authors
DI LIJUN [1]
JOONG SUP SHIM [1]
Document Type
Journal article [2]
Date Issued
2021 [1]
2012 [1]
Language
英語English [2]
Source Publication
Cancers [1]
GENES & DEVELOPM... [1]
Indexed By
SCIE [2]
Funding Organization
Funding Project
×
Knowledge Map
UM
Start a Submission
Submissions
Unclaimed
Claimed
Attach Fulltext
Bookmarks
Browse/Search Results:
1-2 of 2
Help
Selected(
0
)
Clear
Items/Page:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Sort:
Select
Issue Date Ascending
Issue Date Descending
Journal Impact Factor Ascending
Journal Impact Factor Descending
WOS Cited Times Ascending
WOS Cited Times Descending
Submit date Ascending
Submit date Descending
Title Ascending
Title Descending
Author Ascending
Author Descending
Nuclear hkii–p-p53 (Ser15) interaction is a prognostic biomarker for chemoresponsiveness and glycolytic regulation in epithelial ovarian cancer
Journal article
Han, Chae Young, Patten, David A., Kim, Se Ik, Lim, Jung Jin, Chan, David W., Siu, Michelle K.Y., Han, Youngjin, Carmona, Euridice, Parks, Robin J., Lee, Cheol, Di, Li Jun, Lu, Zhen, Chan, Karen K.L., Ku, Ja Lok, Macdonald, Elizabeth A., Vanderhyden, Barbara C., Mes-Masson, Anne Marie, Ngan, Hextan Y.S., Cheung, Annie N.Y., Song, Yong Sang, Bast, Robert C., Harper, Mary Ellen, Tsang, Benjamin K.. Nuclear hkii–p-p53 (Ser15) interaction is a prognostic biomarker for chemoresponsiveness and glycolytic regulation in epithelial ovarian cancer[J]. Cancers, 2021, 13(14), 3399.
Authors:
Han, Chae Young
;
Patten, David A.
;
Kim, Se Ik
;
Lim, Jung Jin
;
Chan, David W.
; et al.
Favorite
|
TC[WOS]:
6
TC[Scopus]:
6
IF:
4.5
/
4.9
|
Submit date:2021/12/08
Cancer Metabolism
Chemoresistance
Epithelial Ovarian Cancer
Hexokinase Ii
P-p53 (Ser15)
Genetic and pharmacological disruption of the TEAD–YAP complex suppresses the oncogenic activity of YAP
Journal article
Yi Liu-Chittenden, Bo Huang, Joong Sup Shim, Qian Chen, Se-Jin Lee, Robert A. Anders, Jun O. Liu, Duojia Pan. Genetic and pharmacological disruption of the TEAD–YAP complex suppresses the oncogenic activity of YAP[J]. GENES & DEVELOPMENT, 2012, 26(12), 1300-1305.
Authors:
Yi Liu-Chittenden
;
Bo Huang
;
Joong Sup Shim
;
Qian Chen
;
Se-Jin Lee
; et al.
Favorite
|
TC[WOS]:
1103
TC[Scopus]:
1138
IF:
7.5
/
10.5
|
Submit date:2019/01/24
Hippo Signaling
Yap
Chemical Biology
Oncogene